Vivos (RDGL) Revenue Growth (1y) (2011 - 2025)
Vivos (RDGL) Revenue Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 6.08% |
| 10 | Vivos | 27.57 Mn | 26.01 Mn | -3,105.00 | 395.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 395.54% |
| Sep 30, 2025 | -62.42% |
| Jun 30, 2025 | 11.11% |
| Mar 31, 2025 | 494.40% |
| Sep 30, 2024 | -28.57% |
| Jun 30, 2024 | 107.69% |
| Mar 31, 2024 | -25.00% |
| Sep 30, 2023 | 7.69% |
| Jun 30, 2023 | -38.10% |
| Mar 31, 2023 | -53.85% |
| Sep 30, 2022 | -56.34% |
| Sep 30, 2021 | 112.67% |
| Sep 30, 2020 | -12.50% |
| Mar 31, 2017 | 0.00% |
| Sep 30, 2016 | -66.37% |
| Mar 31, 2016 | -66.37% |
| Mar 31, 2015 | -14.23% |
| Mar 31, 2014 | -43.34% |
| Sep 30, 2013 | 77.47% |
| Mar 31, 2013 | -63.22% |